⚖️DEA Suspends Dentist's Registration Over Compliance Violations
The Drug Enforcement Administration has issued an Order to Show Cause and suspended the registration of Lona Bibbs-Walker, D.D.S., citing inadequate records on controlled substances and lack of state authority to practice. The order illustrates critical compliance issues in the healthcare industry, emphasizing the importance of strict adherence to regulatory standards.
Learn More💊DEA Revocation of Mariste Pharmacy's Registration - Overview
The Drug Enforcement Administration (DEA) has issued a decision revoking Mariste Pharmacy's registration due to significant violations related to controlled substances. Allegations include failure to address red flags of abuse in prescriptions and inadequate record-keeping, raising concerns for regulatory compliance and public health. The decision emphasizes the importance of adherence to laws governing drug dispensing and security.
Learn More💊DEA Revokes Eagle Pharmacy Registration
The Drug Enforcement Administration issued an Order to Show Cause against Eagle Pharmacy for alleged violations related to dispensing controlled substances without addressing significant red flags of abuse. The case highlights the stringent regulations governing pharmacies and the potential consequences of non-compliance, including revocation of licenses and operational disruptions.
Learn More⚖️DEA Revokes Prescript Pharmaceuticals' Registration for Violations
The Drug Enforcement Administration issued an Order of Revocation against Prescript Pharmaceuticals after it violated federal regulations pertaining to the procurement of controlled substances. The order highlights the importance of compliance with the Controlled Substances Act, especially concerning the requirement for obtaining procurement quotas for manufacturing activities, and could set a precedent affecting other registrants.
Learn More🚫Analysis of Baijes Bissonnet Pharmacy DEA Registration Denial
The Drug Enforcement Administration issued a denial notice to Baijes Bissonnet Pharmacy, highlighting significant compliance failures related to controlled substances. The notice outlines allegations of neglecting red flags indicating prescription abuse and diversion, leading to substantial legal risks and regulatory consequences for the pharmacy.
Learn More💊SpecGx LLC Controlled Substances Import Application Overview
SpecGx LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊Notice of Application for Bulk Manufacturing by Promega Corporation
Promega Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More🌱DEA Notice of Application for Bulk Manufacturing of Marihuana
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.
Learn More🌿Royal Emerald Pharmaceuticals' Application for Controlled Substances Registration
Royal Emerald Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊Patheon API Services’ Application for Controlled Substances Import
Patheon API Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More